Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, Oct. 07, 2024 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Metagenomi Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX) investors of a class action representing investors that bought securities between February 9 and February 13, 2024, inclusive (the “Class Period”). Metagenomi investors have until November 25, 2024 to file a lead plaintiff motion.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
The lawsuit alleges that Metagenomi made false statements regarding its collaboration with Moderna, established through a Strategic Collaboration and License Agreement signed on October 29, 2021. This agreement included several four-year research programs and subsequent agreements for licensed products.
If you want to become the lead plaintiff for the Class, you must submit your documents by November 25, 2024. The lead plaintiff acts as a representative for other class members in managing the litigation. You do not need to be the lead plaintiff to be eligible for any potential recovery.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow